Growth Metrics

Protalix BioTherapeutics (PLX) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 109.54%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 109.54%
Dec 31, 2025 -5.29%
Sep 30, 2025 37.99%
Jun 30, 2025 28.54%
Mar 31, 2025 -17.75%
Dec 31, 2024 55.96%
Sep 30, 2024 42.52%
Jun 30, 2024 41.54%
Mar 31, 2024 6.88%
Dec 31, 2023 -314.76%
Sep 30, 2023 27.73%
Jun 30, 2023 88.44%
Mar 31, 2023 -58.81%
Dec 31, 2022 -213.86%
Sep 30, 2022 0.25%
Jun 30, 2022 11.69%
Mar 31, 2022 32.56%
Dec 31, 2021 -6.13%
Sep 30, 2021 8.20%
Jun 30, 2021 -10.02%
Mar 31, 2021 7.36%
Dec 31, 2020 26.63%
Sep 30, 2020 26.44%
Jun 30, 2020 32.88%
Mar 31, 2020 29.53%
Dec 31, 2019 26.22%
Sep 30, 2019 21.95%
Jun 30, 2019 10.58%
Mar 31, 2019 5.27%
Dec 31, 2018 13.77%
Sep 30, 2018 2.73%
Jun 30, 2018 -11.10%
Mar 31, 2018 -4.06%
Mar 31, 2017 -4.61%
Dec 31, 2016 15.82%
Sep 30, 2016 -10.22%
Jun 30, 2016 -16.26%
Mar 31, 2016 -25.43%
Dec 31, 2015 5.32%
Sep 30, 2015 -2.75%
Jun 30, 2015 -38.33%
Mar 31, 2015 -2.55%
Mar 31, 2014 -13.59%
Dec 31, 2013 -24.55%
Sep 30, 2013 -25.61%
Jun 30, 2013 12.10%